Atlas Trials

Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine

Clinical trial NCT02406729 · UNKNOWN

Trial details

NCT number
NCT02406729
Sponsor
Butantan Institute
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Dengue
Start date
2016-02-22
Primary completion
2021-07-13
Enrollment
16935

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.